BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30689903)

  • 1. Early Changes in Adipose Tissue Morphology, Gene Expression, and Metabolism After RYGB in Patients With Obesity and T2D.
    Katsogiannos P; Kamble PG; Boersma GJ; Karlsson FA; Lundkvist P; Sundbom M; Pereira MJ; Eriksson JW
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2601-2613. PubMed ID: 30689903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time Course of Metabolic, Neuroendocrine, and Adipose Effects During 2 Years of Follow-up After Gastric Bypass in Patients With Type 2 Diabetes.
    Almby KE; Katsogiannos P; Pereira MJ; Karlsson FA; Sundbom M; Wiklund U; Kamble PG; Eriksson JW
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4049-e4061. PubMed ID: 34086911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved glucose metabolism after gastric bypass: evolution of the paradigm.
    Pournaras DJ; Nygren J; Hagström-Toft E; Arner P; le Roux CW; Thorell A
    Surg Obes Relat Dis; 2016; 12(8):1457-1465. PubMed ID: 27387696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.
    Malin SK; Samat A; Wolski K; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
    Int J Obes (Lond); 2014 Mar; 38(3):364-70. PubMed ID: 24166065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes.
    Flynn CR; Albaugh VL; Tamboli RA; Gregory JM; Bosompem A; Sidani RM; Winnick JJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G370-G374. PubMed ID: 31709832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
    Kashyap SR; Daud S; Kelly KR; Gastaldelli A; Win H; Brethauer S; Kirwan JP; Schauer PR
    Int J Obes (Lond); 2010 Mar; 34(3):462-71. PubMed ID: 20029383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Acute Impacts of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass Surgery and Matched Caloric Restriction Diet on Insulin Secretion, Insulin Effectiveness and Non-Esterified Fatty Acid Levels Among Patients with Type 2 Diabetes.
    Thomas F; Smith GC; Lu J; Babor R; Booth M; Beban G; Chase JG; Murphy R
    Obes Surg; 2016 Aug; 26(8):1924-31. PubMed ID: 26729277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Gastric Bypass with a Distal Gastric Pouch on Glucose Tolerance and Diabetes Remission in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Shao Y; Li C; Zhu X; Yao L; Wang H
    Obes Surg; 2019 Jun; 29(6):1889-1900. PubMed ID: 30778846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients.
    Promintzer-Schifferl M; Prager G; Anderwald C; Mandl M; Esterbauer H; Shakeri-Leidenmühler S; Pacini G; Stadler M; Bischof MG; Ludvik B; Luger A; Krebs M
    Obesity (Silver Spring); 2011 Jul; 19(7):1420-6. PubMed ID: 21494227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Roux-en-Y gastric bypass or diabetes support and education on insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes.
    Khoo CM; Chen J; Pamuklar Z; Torquati A
    Ann Surg; 2014 Mar; 259(3):494-501. PubMed ID: 23732262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery.
    Navaneethan SD; Kelly KR; Sabbagh F; Schauer PR; Kirwan JP; Kashyap SR
    Obes Surg; 2010 Mar; 20(3):308-15. PubMed ID: 20217955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced insulin signaling in human skeletal muscle and adipose tissue following gastric bypass surgery.
    Albers PH; Bojsen-Møller KN; Dirksen C; Serup AK; Kristensen DE; Frystyk J; Clausen TR; Kiens B; Richter EA; Madsbad S; Wojtaszewski JF
    Am J Physiol Regul Integr Comp Physiol; 2015 Sep; 309(5):R510-24. PubMed ID: 26062634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Effects of Gastric Bypass Surgery: Is It All About Calories?
    Herzog K; Berggren J; Al Majdoub M; Balderas Arroyo C; Lindqvist A; Hedenbro J; Groop L; Wierup N; Spégel P
    Diabetes; 2020 Sep; 69(9):2027-2035. PubMed ID: 32527768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Roux-en-Y gastric bypass on circulating follistatin, activin A, and peripheral ActRIIB signaling in humans with obesity and type 2 diabetes.
    Pham TCP; Bojsen-Møller KN; Madsbad S; Wojtaszewski JFP; Richter EA; Sylow L
    Int J Obes (Lond); 2021 Feb; 45(2):316-325. PubMed ID: 32873911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Sleeve Gastrectomy and Gastric Bypass on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients: a 2-Year Follow-up.
    Griffo E; Cotugno M; Nosso G; Saldalamacchia G; Mangione A; Angrisani L; Rivellese AA; Capaldo B
    Obes Surg; 2016 Jun; 26(6):1247-53. PubMed ID: 26435537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.
    Camastra S; Gastaldelli A; Mari A; Bonuccelli S; Scartabelli G; Frascerra S; Baldi S; Nannipieri M; Rebelos E; Anselmino M; Muscelli E; Ferrannini E
    Diabetologia; 2011 Aug; 54(8):2093-102. PubMed ID: 21614570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.